AU1453701A - Sequences encoding human neoplastic marker - Google Patents

Sequences encoding human neoplastic marker

Info

Publication number
AU1453701A
AU1453701A AU14537/01A AU1453701A AU1453701A AU 1453701 A AU1453701 A AU 1453701A AU 14537/01 A AU14537/01 A AU 14537/01A AU 1453701 A AU1453701 A AU 1453701A AU 1453701 A AU1453701 A AU 1453701A
Authority
AU
Australia
Prior art keywords
sequences encoding
encoding human
human neoplastic
neoplastic marker
marker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU14537/01A
Inventor
Pin-Ju Chueh
D. James Morre
Dorothy M Morre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purdue Research Foundation
Original Assignee
Purdue Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Research Foundation filed Critical Purdue Research Foundation
Publication of AU1453701A publication Critical patent/AU1453701A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0036—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
AU14537/01A 1999-11-01 2000-11-01 Sequences encoding human neoplastic marker Abandoned AU1453701A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16264499P 1999-11-01 1999-11-01
US60162644 1999-11-01
PCT/US2000/030190 WO2001032673A1 (en) 1999-11-01 2000-11-01 Sequences encoding human neoplastic marker

Publications (1)

Publication Number Publication Date
AU1453701A true AU1453701A (en) 2001-05-14

Family

ID=22586517

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14537/01A Abandoned AU1453701A (en) 1999-11-01 2000-11-01 Sequences encoding human neoplastic marker

Country Status (5)

Country Link
JP (1) JP2003517299A (en)
AU (1) AU1453701A (en)
CA (1) CA2388612A1 (en)
GB (1) GB2371548B (en)
WO (1) WO2001032673A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7053188B2 (en) 2002-02-22 2006-05-30 Purdue Research Foundation Monoclonal antibodies specific for neoplasia-specific NADH:disulfide reductase
US20060292577A1 (en) * 2005-06-27 2006-12-28 Purdue Research Foundation Neoplasia-specific splice variants and methods
GB2441860B (en) * 2006-09-01 2011-06-29 Nox Technologies Inc Detecting Neoplasia-specific tNOX isoforms
US9612243B1 (en) * 2016-05-31 2017-04-04 Mor-Nuco Enterprises, Inc. Methods and compositions for targeted two-dimensional western blot analysis for early cancer detection and cancer diagnosis up to ten years in advance of clinical symptoms of malignant disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605810A (en) * 1994-04-05 1997-02-25 Purdue Research Foundation NADH oxidase assay for neoplasia determination
AU8571598A (en) * 1997-07-17 1999-02-10 Ludwig Institute For Cancer Research Cancer associated nucleic acids and polypeptides

Also Published As

Publication number Publication date
GB2371548B (en) 2004-11-24
GB0210912D0 (en) 2002-06-19
WO2001032673A9 (en) 2002-07-04
JP2003517299A (en) 2003-05-27
CA2388612A1 (en) 2001-05-10
GB2371548A (en) 2002-07-31
WO2001032673A1 (en) 2001-05-10

Similar Documents

Publication Publication Date Title
AU7680300A (en) Human dna sequences
AU5284400A (en) Ankle rehabilitation system
AU3889500A (en) Radiographic reference marker
AU2001275822A1 (en) Multiple-legged walking apparatus
AU2001233626A1 (en) Marker
HU9902483D0 (en) Tyre
AU4431000A (en) Novel use
EP1052799A3 (en) Flexible channeliser
AU2001282149A1 (en) Improved marker
AU3651597A (en) Dna sequences encoding human tcak1 kinase
AU1453701A (en) Sequences encoding human neoplastic marker
AU2001295841A1 (en) Human dna sequences
AU5836700A (en) Peptides for therapeutic use
AU2092901A (en) Polynucleotides encoding human protease homologs
AU2579401A (en) Brain protein markers
AU4456800A (en) Human hac3
AUPQ078799A0 (en) New use
AU2001244096A1 (en) Limb exercise system
AU2669501A (en) New use
AU7935600A (en) Cephalic pain susceptibility marker
AU2001292897A1 (en) Novel therapy
AU6141299A (en) Partial coil-in-coil tubing
AU2001289127A1 (en) Tumor treatment
AU3158701A (en) New use
AU2001236884A1 (en) Flexible multi-packing system

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase